Video

CURE Community Vlog: Cancer Diagnoses Can Be a Distant Memory

Author(s):

Kristie L. Kahl

“When time passes, and you look back it seems like a distant memory.”

In 2016, Juliana’s world was turned upside down when she was diagnosed with Acute promyelocytic leukemia (APL) — an aggressive type of acute myeloid leukemia in which there are too many immature blood-forming cells (promyelocytes) in the blood and bone marrow.

“When time passes, and you look back it seems like a distant memory,” she said. “There's times I'm like, ‘Did I really go through that?’ There are times that I do things like this I share my story and I'm like, this seems like an out of body experience. This doesn't seem like it happened to me.”

Related Videos
Image of man with grey hair.
Image of woman with black hair.
Image of a smiling woman with brown hair.
Image of a woman with short brown hair, wearing glasses.
Image of man with brown hair.
Image of woman with blonde hair.
Image of a woman with brown shoulder-length hair, wearing a khaki colored blazer.
Image of a man wearing a black button-up shirt.
Image of man with black hair.
Image of a man with dark hair and some facial hair.
Related Content
Image of a smiling woman with brown hair.
December 20th 2024

How to Self Advocate When Insurance Says No to Cancer Treatment Coverage

Ashley Chan
When insurance denies coverage of cancer treatment, patients with cancer don’t need to take no for an answer, an expert explained.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of Dr. Brandon Blue.
December 17th 2024

Black Patients With Myeloma Face Taste, Skin Side Effects from Talvey

Alex Biese
Black patients may be more affected by certain side effects from Talvey compared with White patients with multiple myeloma, an expert told CURE®.
Top Headlines on CAR-T Cell Therapy
December 4th 2023

Top Headlines on CAR-T Cell Therapy

Alex Biese Brielle Benyon
From FDA concerns to a potential new drug, CAR-T cell therapies were dominating oncology headlines last week.
Image of blood test.
December 10th 2024

Venclexta Plus Mavenclad Boosts Response Rates in AML, MDS

Ariana Pelosci
The Venclexta-based regimen improved complete response rates in patients with acute myeloid leukemia and myelodysplastic syndromes.
Illustration of blood cells.
December 9th 2024

Calquence Plus Venclexta Combo May Improve Survival in Frontline CLL

Kristie L. Kahl
Calquence plus Venclexta, with or without Gazyva, improved progression-free survival over the standard-of-care chemoimmunotherapy in patients with untreated chronic lymphocytic leukemia.